A potential game-changer in contract research services domain & I’m talking about the latest concept that
Pun apart, if indeed this turns out like it’s promised, a scientist in any part of the world will be able to simultaneously prescribe & iterate-on (with the robotic handlers) the experiments that she/he outsourced. This in turn will make it easy for more drug discovery start-ups to emerge (including some garage innovators too..) & pursue their dreams in a quicker, cheaper & more efficient way (~ the likes of DNAnexus claim that as scale emerges, it’s possible that a whole human genome can be sequenced for a mere $1000!)
The above scenario also implies that scale is a possibility & efficiency at scale an absolute need for any player in this emerging domain.
With only JIT availability of both laboratory & equipment consumables as a probable potential 'scale-limiting' bottleneck, I won't be surprised if the domain of cloud contract laboratory services (I wouldn’t yet call this research..) is quickly populated & dominated by the likes of Life Technologies, a process likely starting with acquisition of buyer organizations by these technology platform & consumable behemoths.
An exciting prospect surely for a scientist currently hyperventilating while awaiting the outcome of an outsourced experiment.
No comments:
Post a Comment